Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6122646 | Journal of Infection | 2016 | 12 Pages |
Abstract
This study reports for the first time that anti-HBHA IgA could have the potential as a biomarker of protective immunity. In addition, non-methylated, recombinant HBHA-induced IFN-γ could be used as a biomarker of protective immunity and latent TB.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Mulugeta Belay, Mengistu Legesse, Adane Mihret, Tom H.M. Ottenhoff, Kees L. Franken, Gunnar Bjune, Fekadu Abebe,